Intellia Therapeutics
NTLA
NTLA
363 hedge funds and large institutions have $8.34B invested in Intellia Therapeutics in 2021 Q3 according to their latest regulatory filings, with 72 funds opening new positions, 130 increasing their positions, 113 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
6.79% less ownership
Funds ownership: 91.42% → 84.63% (-6.8%)
17% less capital invested
Capital invested by funds: $10B → $8.34B (-$1.68B)
33% less funds holding in top 10
Funds holding in top 10: 12 → 8 (-4)
Holders
363
Holding in Top 10
8
Calls
$99.9M
Puts
$94M
Top Buyers
| 1 | +$79.1M | |
| 2 | +$75.9M | |
| 3 | +$60.6M | |
| 4 |
Morgan Stanley
New York
|
+$60.1M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$50.4M |
Top Sellers
| 1 | -$149M | |
| 2 | -$126M | |
| 3 | -$97.6M | |
| 4 |
NAMA
Nikko Asset Management Americas
New York
|
-$89.1M |
| 5 |
JPMorgan Chase & Co
New York
|
-$54M |